Namwiwat Medical Corporation PCL (BKK: NAM)
Thailand
· Delayed Price · Currency is THB 4.620
+0.060 (1.32%)
Nov 22, 2024, 10:00 AM ICT
NAM Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 161.99 | 200.75 | 175.71 | 174.65 | 111.83 |
| Depreciation & Amortization | 27.97 | 25.66 | 20.41 | 17.67 | - |
| Other Amortization | 4.78 | 3.97 | 0.9 | 0.41 | 0.34 |
| Loss (Gain) From Sale of Assets | -10.13 | -10.28 | -5.44 | -1.22 | -0.16 |
| Asset Writedown & Restructuring Costs | - | -1.23 | 2.35 | 0.42 | 17.6 |
| Loss (Gain) From Sale of Investments | -2.5 | -2.16 | -0.59 | - | -10.65 |
| Loss (Gain) on Equity Investments | - | - | 0.55 | 0.27 | 11.4 |
| Provision & Write-off of Bad Debts | -7.32 | -7.09 | -6.56 | 10.78 | -0.99 |
| Other Operating Activities | -4.04 | 10.67 | -3.92 | 24.3 | 13.46 |
| Change in Accounts Receivable | -13.78 | 52.85 | -194.59 | -11.15 | -14.81 |
| Change in Inventory | -32.39 | 17.12 | 27.96 | -203.31 | -87.6 |
| Change in Accounts Payable | -10.98 | -54.37 | 25.53 | 53.17 | -12.14 |
| Change in Unearned Revenue | -7.1 | -14.62 | 0.64 | 6.18 | 23.47 |
| Change in Other Net Operating Assets | -149.51 | 37.43 | -124.13 | 21.45 | 52.95 |
| Operating Cash Flow | -42.99 | 258.68 | -81.16 | 93.61 | 104.71 |
| Operating Cash Flow Growth | - | - | - | -10.60% | - |
| Capital Expenditures | -44.69 | -30.41 | - | - | - |
| Sale of Property, Plant & Equipment | 1.53 | 1.12 | - | - | - |
| Sale (Purchase) of Intangibles | -12.7 | -8.42 | -53.6 | -0.97 | -0.65 |
| Investment in Securities | - | 200 | -300 | - | 35.2 |
| Investing Cash Flow | -53.73 | 162.28 | -392.04 | -32.3 | -144.22 |
| Short-Term Debt Issued | - | - | - | 5 | 33 |
| Long-Term Debt Issued | - | - | - | 24 | 115 |
| Total Debt Issued | - | - | - | 29 | 148 |
| Short-Term Debt Repaid | - | - | -67.62 | -34.88 | -75.99 |
| Long-Term Debt Repaid | - | -36.35 | -37.69 | -43.05 | -37.39 |
| Total Debt Repaid | -31.42 | -36.35 | -105.31 | -77.93 | -113.39 |
| Net Debt Issued (Repaid) | -31.42 | -36.35 | -105.31 | -48.93 | 34.61 |
| Issuance of Common Stock | 784.08 | 784.08 | 839.39 | - | - |
| Common Dividends Paid | -134.39 | -232.05 | -242.5 | - | - |
| Financing Cash Flow | 618.27 | 515.67 | 491.58 | -48.93 | 34.61 |
| Net Cash Flow | 521.54 | 936.64 | 18.38 | 12.38 | -4.9 |
| Free Cash Flow | -87.69 | 228.27 | -81.16 | 93.61 | 104.71 |
| Free Cash Flow Growth | - | - | - | -10.60% | - |
| Free Cash Flow Margin | -9.36% | 20.69% | -7.38% | 9.40% | 15.42% |
| Free Cash Flow Per Share | -0.13 | 0.37 | -3.09 | 4.68 | 5.24 |
| Cash Interest Paid | 13.51 | 14.05 | 13.45 | 11.2 | 8.69 |
| Cash Income Tax Paid | 49.87 | 50.71 | 54.5 | 29.14 | 16.17 |
| Levered Free Cash Flow | - | 182.37 | -173.57 | 38.41 | - |
| Unlevered Free Cash Flow | - | 192.2 | -165.46 | 47.19 | - |
| Change in Net Working Capital | - | -43.78 | 273.2 | 110.83 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.